In a 13D filing on Plug Power (NASDAQ:PLUG), hedge fund Air Liquide Investissements d’Avenir et de Demonstration disclosed a 9.4%, or 10,971,890 share, stake in the company. The firm did not hold shares at the end of the latest quarter ending December 31, 2013. Plug Power Inc (NASDAQ:PLUG) stock performance was 4.19% in last session…
Gordmans Stores, Inc. (NASDAQ:GMAN) will open its third Idaho store 9 a.m. Thursday at Parkcenter Boulevard and Apple Street. The company has existing stores in Nampa and Meridian.Gordmans Stores, Inc. (NASDAQ:GMAN) stock performance was -0.83% in last session and finished the day at $5.97. Traded volume was 63,628 million shares in the last session and…
Inovio Pharmaceuticals Inc (NYSEMKT:INO)’s shares climbed 4.96% to $3.60. The company on Mar. 17 reported financial results for the fourth quarter and year ended Dec. 31, 2013. Total revenue was $1.7 million and $13.5 million for the quarter and year ended December 31, 2013, as compared to $1.1 million and $4.1 million for the same…
Lentuo International Inc. (NYSE:LAS) a leading non-state-owned automobile retailer headquartered in Beijing, today announced that it has signed a strategic agreement with China Orient Tiantong Capital Management Ltd. a subsidiary of China Orient Asset Management Corporation, a major state-owned financial asset management company. Lentuo International Inc. (ADR) (NYSE:LAS) stock performance was -5.74% in last session…
Ever since highly-successful messaging startup WhatsApp was bought out by Facebook Inc (NASDAQ:FB) for $19 billion a few weeks ago, WhatsApp users have been asking for reassurance regarding their privacy after the deal with the social media giant closes. Facebook Inc (NASDAQ:FB) stock performance was 1.51% in last session and finished the day at $68.74….
The iShares Biotechnology Indexhas fallen 2.46% in the last month of trading, and biotech stalwarts Celgene (NASDAQ:CELG) and Gilead Sciences (NASDAQ:GILD ) are both down over 8%. What’s most surprising is that Celgene and Gilead are expected to have strong years in terms of earnings and the development of their respective clinical pipelines. Gilead Sciences,…
